ACCOUNTS - Final Accounts preparation

Registered number: 13318591

DAIM PHARMA LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2025

DAIM PHARMA LTD

CONTENTS

	Page
Company information	1
Balance sheet	2
Notes to the financial statements	3

DAIM PHARMA LTD

COMPANY INFORMATION

Directors	N T Daubeney
	P E F Daubeney
	T G Orban


Registered number	13318591


Registered office	16 Great Queen Street
	London
	WC2B 5AH


Accountants	Blick Rothenberg Limited
	Chartered Accountants
	16 Great Queen Street
	Covent Garden
	London
	WC2B 5AH

Page 1

REGISTERED NUMBER:13318591

DAIM PHARMA LTD

BALANCE SHEET

AS AT 30 JUNE 2025

	2025	2024
Note	£	£

Current assets
Debtors: amounts falling due within one year	4	1	1
Net assets		1	1

Capital and reserves
Called up share capital	5	1	1
Total equity		1	1

For the year ended 30 June 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by:

N T Daubeney

Director

Date: 11 May 2026

The notes on page 3 form part of these financial statements.

Page 2

DAIM PHARMA LTD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2025

1.	General information

Daim Pharma Ltd is a private company limited by shares incorporated in England and Wales. Its registered office is 16 Great Queen Street, London, WC2B 5AH.

The company has not traded during the period. During the period, the company received no income and incurred no expenditure and therefore made neither profit nor loss.

The financial statements are presented in Sterling (£). Monetary amounts in the financial statements are rounded to the nearest £.

2.Accounting policies

2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

Employees

The average monthly number of employees, including directors, during the year was 0 (2024 - 0).

Debtors

					2025	2024
					£	£


Amounts owed by group undertakings	1	1

5.	Share capital
		2025	2024
		£	£

Allotted, called up and fully paid

1 (2024 - 1) Ordinary share of £1.00	1	1

6.	Parent undertaking

The immediate parent undertaking is Phaim Pharma Ltd. Group financial statements are not prepared.

Page 3